Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05736198 · ClinicalTrials.gov registry record
Comparison of Two Sedation Regimens for Awake Fiberoptic Intubation
A clinical trial of Awake Fiberoptic Intubation and Difficult Airway, sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- 96
- Enrollment target
- 1
- Study location
NCT05736198 is a study of Awake Fiberoptic Intubation and Difficult Airway that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 96 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05736198, a study of Awake Fiberoptic Intubation and Difficult Airway, is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- 96 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the effects of different sedation drugs used for the awake fiberoptic intubation procedure. Benzodiazapines and narcotics (such as midazolam and fentanyl) are standard drugs used for sedation during awake fiberoptic intubation. Dexmedetomidine, midazolam, and fentanyl are approved by the Food and Drug Administration (FDA) procedural sedation. These drugs might be given to the patient regardless of their participation in the study. In addition to midazolam and fentanyl study subjects will also receive either dexmedetomidine or a placebo (a salt solution that contains no drug). It is believed that dexmedetomidine will not slow down breathing as much as the combination of the valium-like drug and narcotic. In our study, we are trying to determine if this is the best drug for sedation during an awake fiberoptic procedure.
Conditions Studied
Interventions
- DRUG Dexmedetomidine
Study Locations (1)
Illinois
- University of Illinois - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2024-08-12 |
| Est. Completion | 2034-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05736198
The ClinicalTrials.gov registry entry for NCT05736198 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Awake Fiberoptic Intubation appearing as the primary indexed condition, and to 1 intervention - of which Dexmedetomidine is the first listed.
NCT05736198 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT05736198 about?
NCT05736198 is a clinical study titled "Comparison of Two Sedation Regimens for Awake Fiberoptic Intubation". The purpose of this study is to examine the effects of different sedation drugs used for the awake fiberoptic intubation procedure. Benzodiazapines and narcotics (such as midazolam and fentanyl) are standard drugs used for sedation during awake fiberoptic intubation. Dexmedetomidine, midazolam, and ...
What is the current status of trial NCT05736198?
This trial is currently recruiting. The enrollment target is 96 participants. The study started on 2024-08-12. Estimated completion is 2034-03-01.
What conditions does trial NCT05736198 study?
This clinical trial studies the following conditions: Awake Fiberoptic Intubation, Difficult Airway.
What interventions are being tested in trial NCT05736198?
The interventions under investigation include: Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT05736198?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05736198 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.